Navigation Links
Enoxaparin To Become The Standard Treatment During Procedures For Blocked Arteries

In a new study by researchers from the University of Kentucky being claims to one day change the standard treatment for preventing blood clots during procedures so// as to open up blocked arteries that feed the heart.

According to Dr. Steven Steinhubl, the co-chairman and senior author of the study that is to appear in the latest issue of the New England Journal of Medicine, has claimed that the drug ‘Enoxaparin’, that has been studied has the potential to become a standard treatment during the procedures of stent and angioplasty. Explaining that the current standard of care is to give patients unfractionated heparin, he however cautioned that more research is necessary to come to a definitive conclusion.

Steinhubl, an interventional cardiologist and researcher at UK's Linda and Jack Gill Heart Institute, said that while elective stent and angioplasty procedures to clear blocked arteries are generally safe, a small percentage of patients will experience significant bleeding due to the procedure that can increase the cost and duration of the hospital stay and, in rare instances, even cause death.

In the study, researchers examined Enoxaparin to determine if it is a safe and effective anti-clotting drug, carrying less risk for bleeding following the procedure than unfractionated heparin.

The study found that major bleeding was cut by more than half in patients receiving Enoxaparin. It also showed that doctors were much more likely to achieve the targeted level of blood thinning for their patients with Enoxaparin compared with unfractionated heparin.

"Bleeding following a stent placement or angioplasty is an event that is not only dangerous for patients, but also carries a financial burden for the health care industry as a whole," Steinhubl said. "Millions of these procedures are successfully performed at hospitals across the United States each year. It is important that we make what has become a relatively sa fe procedure even safer by finding a drug that will effectively prevent blood clots and not put patients at risk for unnecessary bleeding. This study, which was designed to test the safety of Enoxaparin, is one of the first steps we as cardiologists are taking to reach that goal."

Source-Eurekalert
VI
'"/>




Related medicine news :

1. Overweight children Dont Necessarily Become overweight adults
2. Girls Who Undergo Genital Mutilation Can Become Infertile
3. Genetic Tests Could Become As Affordable As Blood Tests
4. Obesity Among Children May Become a Major Problem
5. Manned Mars Mission May Become A Reality
6. Malaria Detecting Watch May Become A Health Hazard
7. Children Of Alcoholics Tend to Become Drug Abusers In Adulthood
8. Kerala To Become Testing Center For US Bound Nurses
9. Himachal Pradesh Fails To Become Health Tourism Center
10. Cancer Treatment To Become Less Expensive
11. India Can Become Major HIV Drugs Producer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... ... Talented host, actor Rob Lowe, is introducing a segment ... of "Success Files," which is an award-winning educational program broadcasted on PBS Member ... with passion and integrity. , Sciatica occurs when the sciatic nerve in the ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... ... Planet Fitness, one of the largest and fastest growing franchisors and operators ... location in Covington, LA at 401 N. U.S. Highway 190, in January of 2018. ... in the Holiday Square shopping center. Its location allows it to serve both Covington ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... , and named its founder as Diplomat,s chief information ... Tennessee , will operate under Diplomat subsidiary Envoy ... for health care partners to include IT outsourcing, consulting, ... "In an interoperable world, technology delivers comprehensive insight and ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology: